Healthcare -
Biotechnology - NASDAQ - US
$ 7.58
-2.57 %
$ 162 M
Market Cap
-1.53
P/E
ENTA - TOTAL RECEIVABLES
Total Receivables ENTA - Enanta Pharmaceuticals, Inc.
6.65 M
LAST VALUE
-63.19%
2 YEAR CAGR
-33.55%
5 YEAR CAGR
3.99%
10 YEAR CAGR